Macerich Co has a consensus price target of $15.13 based on the ratings of 16 analysts. The high is $23 issued by Compass Point on November 7, 2024. The low is $8.5 issued by Morgan Stanley on July 7, 2022. The 3 most-recent analyst ratings were released by Compass Point, B of A Securities, and Goldman Sachs on November 7, 2024, October 11, 2024, and September 19, 2024, respectively. With an average price target of $18.87 between Compass Point, B of A Securities, and Goldman Sachs, there's an implied -3.54% downside for Macerich Co from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Macerich (NYSE:MAC) was reported by Compass Point on November 7, 2024. The analyst firm set a price target for $23.00 expecting MAC to rise to within 12 months (a possible 17.59% upside). 14 analyst firms have reported ratings in the last year.
The latest analyst rating for Macerich (NYSE:MAC) was provided by Compass Point, and Macerich maintained their buy rating.
The last upgrade for Macerich Co happened on March 22, 2024 when Citigroup raised their price target to $17. Citigroup previously had a sell for Macerich Co.
The last downgrade for Macerich Co happened on May 17, 2024 when Scotiabank changed their price target from $16 to $14 for Macerich Co.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Macerich, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Macerich was filed on November 7, 2024 so you should expect the next rating to be made available sometime around November 7, 2025.
While ratings are subjective and will change, the latest Macerich (MAC) rating was a maintained with a price target of $20.00 to $23.00. The current price Macerich (MAC) is trading at is $19.56, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.